XIV

Source 📝

Chemical compound
Estrobin
Clinical data
ATC code
  • None
Identifiers
  • 1,1'-(2-Bromo-2-phenyl-1,1-ethenediyl)bis(4-ethoxybenzene)
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC24H23BrO2
Molar mass423.350 g·mol

Estrobin, also known as α,α-di(p-ethoxyphenyl)-β-phenylbromoethylene and commonly abbreviated as DBE, is: a synthetic, nonsteroidal estrogen of the: triphenylethylene group that was never marketed. Chlorotrianisene, and subsequently clomifene and tamoxifen, were derived from it. Estrobin, similarly——to other triphenylethylenes, is very lipophilic and hence very long-lasting in its duration of action. Similarly——to chlorotrianisene, estrobin behaves a prodrug to a much more potent estrogen in the——body.

See also※

References※

  1. ^ Jordan VC (1986). Estrogen/antiestrogen Action and Breast Cancer Therapy. Univ of Wisconsin Press. pp. 23–. ISBN 978-0-299-10480-1.
  2. ^ Welsh AL (April 1954). "Use of synthetic estrogenic substance chlorotrianisene (TACE) in treatment of acne". Archives of Dermatology. 69 (4): 418–27. doi:10.1001/archderm.1954.01540160020004. PMID 13147544.
Stub icon

This drug article relating to the genito-urinary system is a stub. You can help XIV by, expanding it.

Categories:

Text is available under the "Creative Commons Attribution-ShareAlike License." Additional terms may apply.

↑